Otero County Hospital Association

Otero County Hospital Association was paid $73.18M by Medicaid between Jan 2018 and Dec 2024, across 416 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 12% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	187,229	$8.32M
2019	168,263	$7.90M
2020	147,125	$6.88M
2021	176,502	$8.82M
2022	229,753	$11.76M
2023	265,032	$14.85M
2024incomplete	237,071	$14.65M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	109,312	102,448	$8.61M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.0%	27,639	25,579	$5.88M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	7.9%	69,165	57,227	$5.75M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.1%	15,619	14,231	$4.44M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.7%	26,478	25,051	$4.14M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.6%	79,323	73,045	$4.12M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.3%	7,190	6,844	$2.41M
70450	Computed tomography, head or brain; without contrast material	2.0%	7,651	7,195	$1.47M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.8%	22,631	19,967	$1.31M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.6%	6,731	6,261	$1.20M
80053	Comprehensive metabolic panel	1.6%	58,225	49,412	$1.18M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.4%	19,409	16,927	$1.02M

404 more codes

11043		1.3%	9,622	$961K
71045	Radiologic examination, chest; single view	1.2%	20,066	$885K
96375	Therapeutic injection; each additional sequential IV push	1.2%	16,439	$869K
G0378	Hospital observation service, per hour	1.1%	3,210	$816K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	8,333	$796K
87631		1.1%	8,184	$792K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	1.1%	7,491	$783K
96361	Intravenous infusion, hydration; each additional hour	1.1%	19,397	$770K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.0%	1,872	$756K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.0%	18,907	$744K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.0%	62,066	$733K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	9,869	$731K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,664	$607K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	7,418	$521K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	4,731	$508K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	4,799	$501K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,613	$496K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	28,693	$466K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,045	$466K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,598	$452K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,273	$442K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	27,599	$435K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	3,069	$430K
99215	Doctor's office visit, returning patient (complex)	<1%	4,471	$395K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	4,114	$389K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,713	$389K
95811		<1%	853	$368K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	10,328	$357K
71046	Radiologic examination, chest; 2 views	<1%	5,616	$355K
99232	Hospital visit by a doctor, follow-up day	<1%	6,432	$341K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,677	$323K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	11,669	$316K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	15,599	$316K
84443	Thyroid stimulating hormone (TSH)	<1%	13,123	$287K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	6,923	$284K
99204	Doctor's office visit, new patient (more involved)	<1%	2,607	$270K
36415	Collection of venous blood by venipuncture	<1%	62,160	$265K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,051	$262K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,183	$260K
90834	Psychotherapy session, about 45 minutes	<1%	1,611	$259K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,865	$249K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	13,625	$235K
99203	Doctor's office visit, new patient (routine)	<1%	2,997	$235K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	31,113	$222K
90472	Immunization administration, each additional vaccine (list separately)	<1%	7,547	$219K
99442		<1%	2,952	$216K
93017		<1%	1,577	$214K
73562		<1%	2,089	$208K
84484		<1%	13,101	$205K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	409	$196K
90792	Psychiatric diagnostic evaluation with medical services	<1%	1,609	$193K
76830	Ultrasound, transvaginal	<1%	1,666	$187K
73610		<1%	1,794	$187K
64635		<1%	384	$178K
81001		<1%	31,660	$173K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	4,637	$169K
76801		<1%	1,737	$169K
64493		<1%	544	$167K
73130		<1%	2,200	$166K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,867	$166K
83690		<1%	13,009	$165K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	1,589	$165K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,757	$162K
73030		<1%	2,001	$156K
87428		<1%	2,186	$151K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	4,158	$147K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	370	$146K
73630		<1%	1,902	$140K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,791	$134K
87086	Culture, bacterial; quantitative colony count, urine	<1%	9,796	$131K
80306		<1%	9,239	$129K
59025	Fetal non-stress test	<1%	1,498	$121K
72100		<1%	1,356	$118K
64636		<1%	592	$113K
71250		<1%	713	$113K
80061	Lipid panel	<1%	6,681	$111K
64483		<1%	407	$109K
99443		<1%	1,034	$109K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	10,387	$102K
84703		<1%	7,903	$102K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	852	$97K
73110		<1%	1,466	$94K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,674	$94K
83605		<1%	4,967	$89K
93971		<1%	920	$87K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	1,089	$83K
87070		<1%	5,307	$81K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,027	$79K
72131		<1%	306	$77K
83880		<1%	3,754	$77K
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	1,635	$76K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	455	$71K
70486		<1%	372	$68K
99177		<1%	1,831	$66K
87641		<1%	2,365	$66K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,596	$65K
99223	Prolong inpt eval add15 m	<1%	409	$65K
85610		<1%	11,725	$64K
64494		<1%	584	$63K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	2,026	$62K
87040		<1%	4,125	$61K
94726		<1%	578	$56K
94060		<1%	699	$55K
86140		<1%	5,578	$55K
99239	Hospital discharge day management, more than 30 minutes	<1%	553	$54K
93000		<1%	4,937	$51K
90791	Psychiatric diagnostic evaluation	<1%	334	$51K
74021		<1%	410	$49K
81025		<1%	5,323	$49K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	146	$48K
87807		<1%	3,640	$48K
74018		<1%	681	$47K
99308	Subsequent nursing facility care, per day, straightforward	<1%	2,699	$46K
80048	Basic metabolic panel (calcium, ionized)	<1%	3,481	$43K
87186		<1%	4,875	$42K
86900		<1%	2,858	$41K
J2704	Injection, propofol, 10 mg	<1%	7,006	$40K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	2,285	$39K
83735		<1%	4,754	$38K
20610		<1%	919	$38K
96376		<1%	2,595	$36K
90474		<1%	2,134	$36K
J7050	Infusion, normal saline solution, 250 cc	<1%	1,791	$36K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,035	$36K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,036	$36K
73560		<1%	1,049	$35K
J2785	Injection, regadenoson, 0.1 mg	<1%	558	$35K
86850		<1%	2,347	$35K
87077		<1%	4,941	$34K
87640		<1%	1,210	$33K
99173		<1%	1,246	$32K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	317	$32K
84702		<1%	1,414	$31K
73502		<1%	628	$31K
99441		<1%	642	$29K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	472	$29K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	81	$28K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	91	$28K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	79	$28K
99238	Hospital discharge day management, 30 minutes or less	<1%	460	$27K
90832	Psychotherapy session, about 30 minutes	<1%	160	$27K
82607		<1%	1,788	$27K
90837	Psychotherapy session, about an hour	<1%	212	$26K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	239	$25K
86769		<1%	1,080	$25K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	56	$25K
82550		<1%	1,463	$25K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	246	$25K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	108	$25K
84439		<1%	2,207	$23K
72040		<1%	269	$23K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	184	$22K
73565		<1%	580	$21K
76813		<1%	342	$21K
82728		<1%	1,361	$21K
36591		<1%	614	$21K
85379		<1%	1,649	$20K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	5,104	$20K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	8,782	$20K
96367		<1%	573	$20K
94729		<1%	596	$18K
76641		<1%	138	$18K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,145	$18K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,754	$17K
82962		<1%	6,561	$17K
J7030	Infusion, normal saline solution , 1000 cc	<1%	14,612	$17K
11046		<1%	74	$16K
92551		<1%	1,427	$16K
88342		<1%	444	$16K
82803		<1%	495	$16K
99205	Prolong outpt/office vis	<1%	126	$16K
83550		<1%	1,512	$16K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	13,024	$15K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	268	$15K
73080		<1%	266	$15K
83970		<1%	616	$15K
77063	Screening digital breast tomosynthesis, bilateral	<1%	453	$15K
93016		<1%	971	$14K
64484		<1%	147	$14K
86592		<1%	1,848	$14K
76536		<1%	118	$14K
88307		<1%	165	$13K
86703		<1%	964	$13K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,678	$13K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,041	$13K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	713	$13K
36600		<1%	399	$13K
73090		<1%	154	$13K
99245		<1%	57	$13K
85652		<1%	2,090	$13K
85730		<1%	1,767	$12K
87653		<1%	292	$12K
73140		<1%	207	$12K
84436		<1%	1,334	$11K
97602		<1%	186	$11K
83540		<1%	1,309	$11K
88304		<1%	839	$11K
01935		<1%	139	$11K
77066	Tomosynthesis, mammo	<1%	69	$11K
99460		<1%	121	$11K
81002		<1%	5,191	$11K
84153		<1%	573	$11K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	597	$11K
86803		<1%	472	$10K
76770		<1%	91	$10K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	60	$10K
90715		<1%	598	$10K
82570		<1%	1,418	$9K
93018		<1%	971	$9K
87340		<1%	772	$9K
80074		<1%	229	$9K
72110		<1%	92	$9K
82043		<1%	1,126	$9K
87205		<1%	1,957	$8K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	12,139	$8K
70491		<1%	25	$8K
86038		<1%	475	$8K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	719	$8K
93976		<1%	51	$8K
J1815	Injection, insulin, per 5 units	<1%	562	$7K
01992		<1%	72	$7K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	184	$7K
82140		<1%	495	$7K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	15	$7K
64495		<1%	85	$6K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	205	$6K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	13	$6K
80305		<1%	550	$6K
86756		<1%	310	$6K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	70	$6K
95251		<1%	207	$6K
82150		<1%	463	$5K
J3490	Unclassified drugs	<1%	1,596	$5K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,020	$5K
73700		<1%	26	$5K
73523		<1%	27	$5K
84100		<1%	831	$5K
80076		<1%	497	$5K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	61	$5K
84480		<1%	337	$5K
82746		<1%	340	$5K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,245	$5K
12001		<1%	48	$5K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	6,924	$5K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	13	$5K
85018		<1%	1,353	$5K
86762		<1%	355	$5K
93225		<1%	69	$5K
85014		<1%	1,352	$5K
83516		<1%	105	$5K
93226		<1%	69	$5K
73590		<1%	70	$4K
90686		<1%	2,602	$4K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	89	$4K
72070		<1%	54	$4K
87634		<1%	63	$4K
01936		<1%	59	$4K
99218		<1%	56	$4K
82950		<1%	646	$4K
84550		<1%	623	$4K
93970		<1%	28	$4K
96127		<1%	607	$4K
84479		<1%	465	$4K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,564	$4K
72050		<1%	40	$4K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	235	$4K
84481		<1%	174	$3K
96161		<1%	789	$3K
74022		<1%	27	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,924	$3K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,912	$3K
87522	Neg quan hep c or qual rna	<1%	54	$3K
99383		<1%	17	$3K
84145		<1%	194	$3K
82248		<1%	427	$3K
12002		<1%	26	$3K
96160		<1%	1,053	$3K
0001A		<1%	69	$3K
0071A		<1%	68	$3K
G0444	Annual depression screening, 5 to 15 minutes	<1%	165	$3K
70498		<1%	13	$3K
0002A		<1%	63	$3K
86780		<1%	221	$2K
99496		<1%	24	$2K
96368		<1%	145	$2K
85027		<1%	285	$2K
95886		<1%	24	$2K
27096		<1%	21	$2K
82247		<1%	317	$2K
70496		<1%	13	$2K
10060		<1%	14	$2K
71101		<1%	25	$2K
95812		<1%	30	$2K
0072A		<1%	40	$2K
86431		<1%	228	$2K
86003		<1%	16	$1K
94618		<1%	13	$1K
73564		<1%	98	$1K
86308		<1%	172	$1K
87210		<1%	256	$1K
29125		<1%	12	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,322	$1K
76981		<1%	14	$1K
82784		<1%	83	$1K
86376		<1%	97	$1K
72170		<1%	18	$1K
99318		<1%	71	$1K
87493		<1%	40	$1K
83655		<1%	68	$1K
J2060	Injection, lorazepam, 2 mg	<1%	1,988	$1K
88142		<1%	504	$1K
90688		<1%	55	$935.61
77089		<1%	39	$926.28
99406		<1%	102	$893.74
90961		<1%	41	$870.12
80055		<1%	13	$831.28
73070		<1%	17	$816.13
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	67	$785.22
20611		<1%	12	$776.72
83013		<1%	12	$774.96
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,199	$706.62
73060		<1%	12	$682.05
90756		<1%	133	$591.60
83721		<1%	93	$590.05
88300		<1%	35	$572.83
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	14	$554.18
80069		<1%	26	$478.46
J2550	Injection, promethazine hcl, up to 50 mg	<1%	600	$475.74
90670		<1%	2,746	$472.11
99459		<1%	33	$462.86
99072		<1%	41	$460.00
90633		<1%	1,025	$453.80
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	330	$446.67
0073A		<1%	13	$440.00
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	673	$388.62
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	255	$379.04
84403		<1%	12	$373.68
90648		<1%	1,177	$352.94
93227		<1%	14	$341.03
99307		<1%	16	$336.28
80164		<1%	18	$329.16
51702		<1%	12	$326.49
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	142	$324.18
96380		<1%	17	$276.90
84146		<1%	12	$225.16
90671		<1%	342	$189.86
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	12	$185.69
86580		<1%	24	$184.03
J7120	Ringers lactate infusion, up to 1000 cc	<1%	742	$170.74
J7510	Prednisolone oral, per 5 mg	<1%	138	$163.69
90680		<1%	2,027	$158.12
94760		<1%	17	$154.83
87045		<1%	12	$147.72
J1644	Injection, heparin sodium, per 1000 units	<1%	321	$143.27
J3360	Injection, diazepam, up to 5 mg	<1%	105	$121.45
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	192	$119.47
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	153	$116.49
88302		<1%	12	$109.48
83037		<1%	12	$106.47
A9585	Injection, gadobutrol, 0.1 ml	<1%	46	$90.17
90619		<1%	13	$74.90
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	34	$70.40
90716		<1%	12	$68.94
90707		<1%	24	$68.94
91307		<1%	118	$40.00
91300		<1%	131	$40.00
J0780	Injection, prochlorperazine, up to 10 mg	<1%	116	$37.92
J3370	Injection, vancomycin hcl, 500 mg	<1%	43	$32.60
J3475	Injection, magnesium sulfate, per 500 mg	<1%	54	$30.25
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	166	$29.46
G0008	Administration of influenza virus vaccine	<1%	33	$24.00
Q2035	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)	<1%	16	$18.24
J3480	Injection, potassium chloride, per 2 meq	<1%	16	$16.41
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	138	$13.93
J1940	Injection, furosemide, up to 20 mg	<1%	23	$9.64
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	218	$8.35
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	152	$8.07
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	12	$8.00
J1790	Injection, droperidol, up to 5 mg	<1%	14	$5.15
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	<1%	14	$0.90
90723		0%	956	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	336	$0.00
90697		0%	167	$0.00
90651		0%	75	$0.00
90677		0%	554	$0.00
G8883	Biopsy results reviewed, communicated, tracked and documented	0%	13	$0.00
90698		0%	359	$0.00
1111F		0%	2,225	$0.00
90656		0%	240	$0.00
3008F		0%	30	$0.00
90696		0%	62	$0.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	14	$0.00
G8708	Patient not prescribed antibiotic	0%	28	$0.00
90710		0%	52	$0.00
G8482	Influenza immunization administered or previously received	0%	29	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	1,729	$0.00
1160F		0%	58	$0.00
90685		0%	99	$0.00
90734		0%	59	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	139	$0.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	0%	38	$0.00
90966		0%	36	$0.00
1159F		0%	58	$0.00
90380		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHECKERT, ROBERT (CHIEF EXECUTIVE OFFICER)